Dr. Lalit Kumar

Brief Profile:

Dr. Lalit Kumar is a renowned expert in the field of Blood Stem Cell / Bone Marrow Transplantation, Haematological Malignancies, and Gynecological Malignancies. With years of experience and expertise, Dr. Kumar has made significant contributions to the field through his research and clinical practice.

One of Dr. Kumar's areas of focus is the role of Bone Marrow Transplantation in treating various haematological malignancies such as Multiple Myeloma and Chronic Myeloid Leukaemia. His extensive knowledge and experience in this field make him a trusted authority for patients seeking effective treatment options.

Additionally, Dr. Kumar has also conducted studies on the role of infections in cancer ovary and cervix. His research sheds light on the complexities involved in managing gynecological malignancies and provides valuable insights for improved patient care.

Dr. Lalit Kumar's expertise extends beyond his clinical practice. He is actively involved in teaching and mentoring young medical professionals, ensuring that his knowledge is passed on to future generations of healthcare providers.

With his dedication to advancing medical science and patient care, Dr. Lalit Kumar continues to be a leading figure in the field of oncology and bone marrow transplantation at Artemis Hospital. Patients can trust him for compassionate care combined with cutting-edge treatments that offer hope for a better future.

Education:

• MBBS & MD (Medicine) - Sarojini Naidu Medical College, Agra.
• DM Medical Oncology - Adyar Cancer Institute, Chennai
• Post-Doctoral Fellowship - Royal Postgraduate Medical School of the Hammersmith Hospital, London.
• Fulbright Scholarship - United States of America.

AWARDS & ACCOMPLISHMENTS

• - Padma Shri Award (2014).
• Dr. B.C. Roy Award (2008) - the highest award by the Indian government in the medical category.
• Indian Council of Medical Research (ICMR) Award.
• Ranbaxy Science Foundation Award.
• Fellowship: Indian Academy of Sciences (FASc).
• Fellowship: National Academy of Medical Sciences of India (FAMS).
• Fellowship: National Academy of Sciences (FNASI).

MEMBERSHIPS & CERTIFICATIONS

• Indo British Health Initiative (IBHI)
• Institute of Women's Health (IFWH) of the University College of London (UCL)
• Expert Committee to examine the Serious Adverse Events (SAE) of deaths occurring during clinical trials